AI Sell-Off: 3 Stocks Investors Should Load Up On

$1 trillion in orders for Nvidia's Blackwell and Rubin systems through end-2027 (up from $500B last year) and management guidance of near-80% revenue growth next quarter highlight accelerating demand. TSMC expects its AI chip business to grow ~60% CAGR from 2024–2029 (25% overall CAGR), while Broadcom's AI semiconductors rose 106% to $8.4B in Q1 FY2026 and its custom AI chip unit targets $100B+ annual revenue by end-FY2027. The author recommends buying Nvidia, TSMC, and Broadcom, noting Broadcom trades at ~28x forward earnings while TSMC and Nvidia are roughly at market multiples.

Analysis

The market is treating the AI hardware story as a demand-driven trifecta (chip designer, foundry, systems), but the more profitable lever may be supply-side tightness and contract structure. Foundry capacity allocation and pricing (TSMC-centric) create a durable pricing umbrella for suppliers that secure long lead-time slots; that umbrella can decouple revenue growth from spot chip cycles and re-rate multiples for firms with binding capacity contracts.

Broadcom’s custom silicon path creates a second-order displacement risk for OEMs that rely on off-the-shelf accelerators: successful bespoke deployments shorten procurement cycles and raise switching costs, turning project wins into multi-year annuities. Conversely, vertical integration by large cloud buyers is the key downside — the marginal dollar of spend shifting in-house compresses growth for external suppliers and would show up first as elongating payment terms and larger inventory builds.

Catalysts cluster across three horizons: near-term earnings and guiding windows (days–months) where inventory and ASP commentary matters; medium-term foundry capacity announcements and process-node transitions (6–24 months); and structural share-shifts driven by hyperscaler silicon strategies and trade policy (2–5 years). Tail risks — sharp capex slowdowns, export-control shocks, or a synchronized hyperscaler pause — can unwind multiple years of forward multiple expansion quickly, so trade structures should favor defined risk or sleeves with skewed upside exposure.

Key Decisions for Investors

• Long Broadcom (AVGO) core position (3–5% portfolio) funded with a 12–18 month hedge: buy AVGO equity and purchase 1-year 15% OTM puts as downside insurance. Rationale: convert potential contract-backed revenue into equity upside while capping drawdown; target +30–50% in 12–18 months if custom deployments scale, protected to a ~15% realized downside (net of put cost).
• Foundry play via TSMC (TSM) LEAPS: buy 18–24 month TSM calls (size 3%) funded by selling nearer-term (6–9 month) calls to monetize implied vol before major capacity/capex updates. Rationale: asymmetric exposure to pricing power and node share gains; target 35–60% upside if pricing/allocations surprise on the upside, cut position if management flags material capacity softness or customer cancellations.
• Pair trade — long AVGO / short NVDA (notional 1:1, 6–12 months): express preference for contract-sticky bespoke revenue vs demand-cyclical fabless exposure. Use options collars to limit tail loss: buy AVGO calls and buy NVDA puts to define max pain. Seek 1.5–2x return if Broadcom executes and hyperscaler spending normalizes; stop-and-reverse if NVDA prints materially stronger-than-guidance order durability.
• High-conviction hedge: small asymmetric long on Intel (INTC) via out-of-the-money 12-month calls (1% portfolio). Rationale: cheap optionality if foundry share or process roadmap surprises; downside limited to premium, upside captures a de-risking of concentration at TSMC or policy-driven reshoring.